Expanding treatment options by selectively targeting the cytokine storm with ruxolitinib in primary hemophagocytic lymphohistiocytosis

Research output: Contribution to journalEditorialAcademicpeer-review

3 Downloads (Pure)
Original languageEnglish
Pages (from-to)374-375
Number of pages2
JournalHaematologica
Volume109
Issue number2
DOIs
Publication statusPublished - 1 Feb 2024

Bibliographical note

©2023 Ferrata Storti Foundation

Cite this